Targeting NETosis: nature’s alarm system in cancer progression

Impact of genetic variants in the solute carrier (<i>SLC</i>) genes encoding drug uptake transporters on the response to anticancer chemotherapy

Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review

Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects

Recent advanced lipid-based nanomedicines for overcoming cancer resistance

The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients

ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies

Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells

Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them

Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers

Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a

Emerging role of MYB transcription factors in cancer drug resistance

HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs

The therapeutic potential of circular RNA in triple-negative breast cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer

Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications

Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia

Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors

Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia

Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer

Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel

Targeting T regulatory (T<sub>reg</sub>) cells in immunotherapy-resistant cancers

Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)


All published articles will preserved here permanently:



All published articles will preserved here permanently: